162 related articles for article (PubMed ID: 11300723)
1. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
2. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.
Chiesa R; Piccardo P; Ghetti B; Harris DA
Neuron; 1998 Dec; 21(6):1339-51. PubMed ID: 9883727
[TBL] [Abstract][Full Text] [Related]
3. V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation.
Chasseigneaux S; Haïk S; Laffont-Proust I; De Marco O; Lenne M; Brandel JP; Hauw JJ; Laplanche JL; Peoc'h K
Neurosci Lett; 2006 Nov; 408(3):165-9. PubMed ID: 17029785
[TBL] [Abstract][Full Text] [Related]
4. Dominant-negative inhibition of prion replication in transgenic mice.
Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
[TBL] [Abstract][Full Text] [Related]
5. The number of octapeptide repeat affects the expression and conversion of prion protein.
Hiraga C; Kobayashi A; Kitamoto T
Biochem Biophys Res Commun; 2009 May; 382(4):715-9. PubMed ID: 19318088
[TBL] [Abstract][Full Text] [Related]
6. In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm.
Yang W; Yang H; Tien P
FEBS Lett; 2006 Jul; 580(17):4231-5. PubMed ID: 16831424
[TBL] [Abstract][Full Text] [Related]
7. PrPSc level and incubation time in a transgenic mouse model expressing Borna disease virus phosphoprotein after intracerebral prion infection.
Sakudo A; Onodera T; Ikuta K
Neurosci Lett; 2008 Jan; 431(1):81-5. PubMed ID: 18155836
[TBL] [Abstract][Full Text] [Related]
8. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
9. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
[TBL] [Abstract][Full Text] [Related]
10. Prions in skeletal muscle.
Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
[TBL] [Abstract][Full Text] [Related]
11. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
12. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
14. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
15. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
17. Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion.
Biasini E; Medrano AZ; Thellung S; Chiesa R; Harris DA
J Neurochem; 2008 Mar; 104(5):1293-308. PubMed ID: 18034781
[TBL] [Abstract][Full Text] [Related]
18. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
[TBL] [Abstract][Full Text] [Related]
19. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
[TBL] [Abstract][Full Text] [Related]
20. Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only.
Crozet C; Lezmi S; Flamant F; Samarut J; Baron T; Bencsik A
J Infect Dis; 2007 Apr; 195(7):997-1006. PubMed ID: 17330790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
